CYX Calyx Ventures Inc

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") is
providing this corporate update further to the update issued on March 24, 2014.


Calyx is the largest shareholder of Agrisoma Biosciences Inc. ("Agrisoma") and
owns 49.98% of the issued and outstanding common shares of Agrisoma. BDC Capital
Inc. ("BDC"), which owns 49.96% of issued and outstanding common shares of
Agrisoma, has advanced to Agrisoma a total of $2 million by way of promissory
notes (the "BDC Notes"). The BDC Notes are the only secured debt of Agrisoma and
have a maturity date of March 31st, 2014.


An Independent Committee of the Calyx Board has been working with financial and
legal advisors to formulate, consider, and propose any and all strategic options
that would be in the best interests of Calyx with respect to its investment in
Agrisoma. As part of this process, meetings have been held with Agrisoma and BDC
to identify and consider financing solutions that would work for all of
Agrisoma's stakeholders, and Calyx put forward a proposal that it believes
accomplishes this.


To date, however, the parties have not reached agreement with respect to future
financing of Agrisoma, and continue to work towards a resolution that preserves
the interests of the various stakeholders.


The Independent Committee of the Board and Calyx's financial advisor continue to
examine all strategic alternatives for Calyx.


The Company also announces that Calyx's nominee to the board of directors of
Agrisoma, Don Konantz, has resigned from Agrisoma's board.


About Calyx

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
focused on renewable fuels including biojet and biodiesel. Calyx is the largest
shareholder of Agrisoma Biosciences Inc., a company which is producing a new
proprietary non-food energy feedstock crop - carinata - which yields oil that
can be refined into fuels that work in existing engines as a 100 percent
petroleum substitute. From seed to sky, fuels produced from carinata
substantially reduce carbon and other harmful emissions, and help to reduce
global petroleum dependence. Carinata was used to fly the world's first 100%
biojet flight, an achievement that Popular Science called one of the top science
events on the planet in 2012. For further information about Calyx, please visit
www.calyxbio.com. For more information on Agrisoma, please visit
www.agrisoma.com. 


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx, as well as other expectations, plans, goals,
objectives, information or statements about future events, conditions, or
performance that may constitute "forward-looking statements" or "forward-looking
information" under applicable securities legislation. Such statements or
information involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control. 


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect.


Although Calyx believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on
forward-looking statements because Calyx can give no assurance that such
expectations will prove to be correct. Forward-looking statements or information
are based on current expectations, estimates and projections that involve a
number of risks and uncertainties which could cause actual results to differ
materially from those anticipated by Calyx and described in the forward-looking
statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx undertakes no obligation to update publicly
or revise any forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by applicable
securities laws or the TSX Venture Exchange. The forward-looking statements or
information contained in this news release are expressly qualified by this
cautionary statement.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
Don Konantz
President & CEO
604-649-5961
dkonantz@calyxbio.com


Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Apr 2024 to May 2024

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From May 2023 to May 2024